Gøtzsche L B
University of Arhus, Medical Department, Arhus Kommunehospital, Denmark.
Acta Endocrinol (Copenh). 1993 Oct;129(4):337-47.
Similar features during chronic amiodarone treatment and hypothyroidism suggest that amiodarone induces a state of "triiodothyronine (T3)-resistance" or "cardiac hypothyroidism", which may predispose the heart to pump failure under conditions with severe strain, such as recovery after cardiac surgery. Disagreements exists as to how amiodarone, and possibly its main metabolite desethylamiodarone, act upon the various receptor systems in the heart. The aim of the present study was to elucidate whether chronic amiodarone treatment leads to a functional reduction in the number of myocardial nuclear T3 receptors, the myocardial tissue T3 concentration and the number of beta-receptors and voltage-operated Ca(2+)-channels. Finally, special attention was drawn to any changes that could contribute to explain previous reports on reduced haemodynamic reserve in animals exposed to severe cardiac strain, such as cardiac surgery. Pigs (72 +/- 2 kg) were assigned randomly to amiodarone treatment (20 mg.kg-1.day-1 for 30 +/- 1 days, N = 8); controls received no medical treatment (N = 6). The left ventricle was evaluated for beta-adrenergic receptors, voltage-operated Ca(2+)-channels, T3 nuclear receptors and tissue T3 concentration. Maximum binding capacity for beta-receptors and Ca(2+)-channels was reduced in amiodarone-treated pigs (by 38%, p < 0.05, and by 52%, p < 0.01) and correlated with tissue drug concentrations for both receptor types (p < 0.05). No changes were observed concerning nuclear T3 receptors. In vitro competition studies revealed that amiodarone, but not desethylamiodarone, possessed binding properties to Ca(2+)-channels, whereas neither of the compounds bound to beta-receptors. Desethylamiodarone, but not amiodarone, competitively inhibited T3 binding to its nuclear receptors. Myocardial T3 was undetectable (< 0.05 nmol/kg wet wt) in amiodarone-treated pigs. From our observations we suggest that the active metabolite desethylamiodarone, rather than the parent drug, is mainly responsible for the observed local hypothyroid-like effects during amiodarone treatment. The observed changes after treatment with low-dose amiodarone in pigs are likely to have biological implications. Functionally, the changes may imply reduced cardiac reserve during conditions of extraordinary strain.
慢性胺碘酮治疗与甲状腺功能减退的相似特征表明,胺碘酮可诱发一种“三碘甲状腺原氨酸(T3)抵抗”或“心脏甲状腺功能减退”状态,这可能使心脏在严重应激状态下(如心脏手术后恢复阶段)易于发生泵衰竭。关于胺碘酮及其主要代谢产物去乙基胺碘酮如何作用于心脏中的各种受体系统,目前仍存在争议。本研究的目的是阐明慢性胺碘酮治疗是否会导致心肌细胞核T3受体数量、心肌组织T3浓度、β受体数量以及电压门控性Ca(2+)通道数量的功能性减少。最后,特别关注那些可能有助于解释先前关于暴露于严重心脏应激(如心脏手术)的动物血流动力学储备降低的报道的变化。将猪(72±2千克)随机分为胺碘酮治疗组(20毫克·千克-1·天-1,持续30±1天,n = 8);对照组不接受药物治疗(n = 6)。对左心室进行β肾上腺素能受体、电压门控性Ca(2+)通道、T3核受体和组织T3浓度的评估。胺碘酮治疗的猪中,β受体和Ca(2+)通道的最大结合能力降低(分别降低38%,p < 0.05;降低52%,p < 0.01),且与两种受体类型的组织药物浓度相关(p < 0.05)。未观察到核T3受体有变化。体外竞争研究表明,胺碘酮而非去乙基胺碘酮具有与Ca(2+)通道的结合特性,而两种化合物均不与β受体结合。去乙基胺碘酮而非胺碘酮竞争性抑制T3与其核受体的结合。胺碘酮治疗的猪心肌中未检测到T3(< 0.05纳摩尔/千克湿重)。根据我们的观察,我们认为活性代谢产物去乙基胺碘酮而非母体药物主要是胺碘酮治疗期间观察到的局部甲状腺功能减退样效应的原因。在猪中低剂量胺碘酮治疗后观察到的变化可能具有生物学意义。从功能上讲,这些变化可能意味着在超常应激状态下心脏储备降低。